These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 30358722

  • 21. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC.
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [Abstract] [Full Text] [Related]

  • 22. Estrogen replacement therapy, atherosclerosis, and vascular function.
    Mikkola TS, Clarkson TB.
    Cardiovasc Res; 2002 Feb 15; 53(3):605-19. PubMed ID: 11861031
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.
    Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB.
    Arteriosclerosis; 1990 Feb 15; 10(6):1051-7. PubMed ID: 2244855
    [Abstract] [Full Text] [Related]

  • 24. Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women.
    Christian RC, Liu PY, Harrington S, Ruan M, Miller VM, Fitzpatrick LA.
    J Clin Endocrinol Metab; 2006 Jul 15; 91(7):2713-20. PubMed ID: 16608893
    [Abstract] [Full Text] [Related]

  • 25. Effects of estrogen treatment on arterial wall structure and function.
    Clarkson TB, Anthony MS, Klein KP.
    Drugs; 1994 Jul 15; 47 Suppl 2():42-51. PubMed ID: 7517833
    [Abstract] [Full Text] [Related]

  • 26. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.
    JAMA; 1998 Aug 19; 280(7):605-13. PubMed ID: 9718051
    [Abstract] [Full Text] [Related]

  • 27. The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.
    Herrington DM, Reboussin DM, Klein KP, Sharp PC, Shumaker SA, Snyder TE, Geisinger KR.
    Control Clin Trials; 2000 Jun 19; 21(3):257-85. PubMed ID: 10822123
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Premenopausal Reproductive Health Modulates Future Cardiovascular Risk - Comparative Evidence from Monkeys and Women.
    Kaplan JR, Manuck SB.
    Yale J Biol Med; 2017 Sep 19; 90(3):499-507. PubMed ID: 28955188
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vascular effects of estrogenic menopausal hormone therapy.
    Reslan OM, Khalil RA.
    Rev Recent Clin Trials; 2012 Feb 19; 7(1):47-70. PubMed ID: 21864249
    [Abstract] [Full Text] [Related]

  • 33. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
    J Clin Endocrinol Metab; 1981 Dec 19; 53(6):1123-32. PubMed ID: 7298796
    [Abstract] [Full Text] [Related]

  • 34. Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis.
    Burke AP, Farb A, Malcom G, Virmani R.
    Am Heart J; 2001 Feb 19; 141(2 Suppl):S58-62. PubMed ID: 11174360
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cardiovascular effects of endogenous estrogen and hormone therapy.
    Bechlioulis A, Naka KK, Calis KA, Makrigiannakis A, Michalis L, Kalantaridou SN.
    Curr Vasc Pharmacol; 2010 Mar 19; 8(2):249-58. PubMed ID: 19485910
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS).
    Wolff EF, He Y, Black DM, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Zhang H, Harman SM, Taylor HS.
    Fertil Steril; 2013 Apr 19; 99(5):1385-91. PubMed ID: 23312232
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.